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PerforationAbstract Neo-adjuvant brachytherapy (NBT) for oesophageal cancer is under rapid development
in recent years and more reports are required to elucidate its complications and drawbacks. Here,
we report a case treated for NBT whose oesophagus was perforated during the procedure and men-
tion necessary precautions to avoid it.
A 73 year old male whose upper gastrointestinal endoscopy showed a lesion extending from 29 cm
to 33 cm of the incisors with a histology of poorly differentiated squamous cell carcinoma, without
metastases. Endoscopic ultrasonography diagnosed a T3 N0 grade tumour. He was selected for
NBT and neo-adjuvant chemotherapy. The patient received 5 Gy in the ﬁrst session of NBT, but
in the second session before receiving the same dosage his control chest X-ray showed the tip of
the catheter to be out of the oesophageal tract.
After conﬁrmation of the perforation by Gastrograﬁn, we performed total oesophagectomy com-
bined with a gastric pull-up procedure.
To our best knowledge, our case is the ﬁrst reported complication related to the direct effect of the
catheter and tissue manipulation rather than the radiation beam.
Weakness in the oesophageal wall due to tumour involvement makes it prone to perforation by any
rigid catheter.
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Cairo University. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Neo-adjuvant brachytherapy (NBT) for oesophageal
cancer is under rapid development in recent years and more
reports are required to elucidate its complications and
drawbacks. Here, we report a case treated for NBT whoseoesophagus was perforated during the procedure and mention
necessary precautions to avoid it.
A 73 year old male presented with dysphagia grade IV to
our outpatient clinic. Upper gastrointestinal endoscopy
showed a lesion extending from 29 cm to 33 cm of incisors
whose pathology turned out to be poorly differentiated squa-
mous cell carcinoma. Thoracic and abdomino-pelvic CT-scans
revealed no metastases. Endoscopic ultrasonography diag-
nosed a T3 N0 grade tumour. After being discussed in weekly
Figure 1 Postero-anterior projection chest X-ray of the patient
after introducing the brachytherapy catheter (opaque object). The
location of the tracheal bifurcation is highlighted in blue.
Figure 2 Intra-operative view of the perforation in the oesoph-
ageal wall. No contamination was observed and total oesophag-
ectomy was performed.
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NBT and neo-adjuvant chemotherapy. The patient received
5 Gy in the ﬁrst session of NBT, but in the second session
before receiving the same dosage his control chest X-ray
showed the tip of the catheter to be out of the oesophageal
tract (Fig. 1). After conﬁrmation of the perforation by Gast-
rograﬁn (Bayer, Germany), the patient underwent a right pos-
tero-lateral thoracotomy where the perforation was found to
be located at the tumour’s site (Fig. 2). Considering the favour-
able general condition of the patient and absence of any tho-
racic contamination, we performed total oesophagectomy
combined with a gastric pull-up procedure. The patient recov-
ered well from the surgery and has ﬁnished an uneventful adju-
vant chemo-radiotherapy.
Based on recent studies, brachytherapy has been suggested
for treatment of some tumours of cervix, prostate, head and
neck, liver, and gastrointestinal tract [1]. The main reason
for interest in brachytherapy is increasing the effective dose
of radiation while limiting the ﬁeld of radiation in order to
reduce radiation-induced complications. Though NBT for
oesophageal cancer is under investigation, it is still far from
being the standard of treatment [2,3]. The main complications
reported with NBT for oesophageal tumours are ﬁstula, steno-
sis, bleeding, perforation, and mediastinitis which are all late
consequences of radiation effects on tissue [3]. To our best
knowledge, our case is the ﬁrst reported complication relatedto the direct effect of the catheter and tissue manipulation
rather than the radiation beam. Weakness in the oesophageal
wall due to tumour involvement makes it prone to perforation
by any rigid catheter. This further emphasizes on the impor-
tance of control X-ray after any high risk manipulation or
intervention. Our experience showed that early primary resec-
tion and repair of such perforations can be successful.
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